Alyeska Files Schedule 13G Showing 4.79M AACT Warrants (7.74%)

Rhea-AI Filing Summary

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report beneficial ownership of warrants to purchase 4,789,194 Class A ordinary shares of Ares Acquisition Corporation II (CUSIP G33033104), representing 7.74% of the outstanding ordinary shares on a basis of 61,859,712 shares outstanding per the issuer's 10-Q filed May 15, 2025. The filing states the warrants are held in the ordinary course of business and were not acquired to change or influence control. Signatures are dated August 14, 2025, and the event date triggering the filing is June 30, 2025.

Positive

• Disclosure of >5% position: Reporting persons disclose warrants equal to 7.74% of outstanding ordinary shares, meeting SEC materiality rules.
• Clear certification of intent: Filing states securities were acquired and are held in the ordinary course of business and not to influence control.
• Joint filing agreement: Parties confirm a joint filing under Rule 13d-1(k), clarifying responsibilities for amendments and accuracy.

Negative

• None.

Insights

Financial Analyst

TL;DR: Holders report warrants equal to 7.74% of AACT's outstanding shares; disclosure is material but indicates no intent to seek control.

The filing discloses beneficial ownership of warrants to purchase 4,789,194 shares, which exceeds the 5% threshold and therefore requires public reporting. The percentage is calculated using 61,859,712 outstanding ordinary shares per the issuer's 10-Q. The certification explicitly states the positions were not acquired to influence control, which reduces near-term governance risk. This is a standard Section 13G disclosure by an investment adviser/group rather than an activist acquisition.

Corporate Governance Expert

TL;DR: Joint filing clarifies shared voting and dispositive power over warrants; no group dissolution or control actions indicated.

The schedule shows shared voting and dispositive power for all reporting persons over the warrants, and a joint filing statement under Rule 13d-1(k) binds the parties to file amendments collectively. Item 10 certification denies intent to alter control, which is important for compliance and shareholder signaling. No additional governance actions, group formation disclosures, or exemptions are asserted.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ARES ACQUISITION CORPORATION II

(Name of Issuer)

Class A Ordinary Shares

(Title of Class of Securities)

G33033104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G33033104

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,789,194.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,789,194.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,789,194.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.74 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. G33033104

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,789,194.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,789,194.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,789,194.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.74 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. G33033104

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,789,194.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,789,194.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,789,194.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.74 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ARES ACQUISITION CORPORATION II
(b)	Address of issuer's principal executive offices: 245 Park Avenue, 44th Floor, New York, NY 10167
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Class A Ordinary Shares
(e)	CUSIP No.: G33033104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,789,194
(b)	Percent of class: 7.74%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 4,789,194
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 4,789,194
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	08/14/2025

Exhibit Information

Item 4. Ownership: The reporting persons are the beneficial owners of warrants to purchase 4,789,194 shares of the Issuer's Ordinary Shares (the "Warrants"). The percentage calculation assumes that there are currently 61,859,712 outstanding shares of Ordinary Shares of the Issuer, based on the Issuer's 10-Q filed with the Securities and Exchange Commission on May 15, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

FAQ

What stake in AACT do Alyeska reporting persons disclose?

They report beneficial ownership of warrants to purchase 4,789,194 shares, representing 7.74% of outstanding ordinary shares based on 61,859,712 shares.

Are the holdings ordinary shares or warrants?

The filing specifies the reporting persons are beneficial owners of warrants to purchase 4,789,194 ordinary shares.

Does the filing state any intent to change or influence control of Ares Acquisition Corporation II (AACT)?

No. The certification states the securities were not acquired and are not held for the purpose of changing or influencing control.

What is the event date and signature date on the Schedule 13G?

The event date requiring the filing is 06/30/2025. Signatures are dated 08/14/2025.

Who are the reporting persons and where are they organized?

Reporting persons are Alyeska Investment Group, L.P. (Delaware), Alyeska Fund GP, LLC (Delaware), and Anand Parekh (United States).